2016
DOI: 10.1039/c6ra02994a
|View full text |Cite
|
Sign up to set email alerts
|

Exenatide loaded PLGA microspheres for long-acting antidiabetic therapy: preparation, characterization, pharmacokinetics and pharmacodynamics

Abstract: We herein fabricated the exenatide-loaded microspheres by a water in oil in oil (W/O/O) method, which presented great effect on glycemic control with low initial burst release and reduced risk of gastrointestinal intolerance and hypoglycemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0
3

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 49 publications
0
23
0
3
Order By: Relevance
“…The CD spectra of exenatide had two specific minima at 209 and 224 nm wavelength, which indicated the presence of α-helix (Figure 8a) [25]. There was no difference between the extracted exenatide from ELPM6 and the unprocessed one, which means that the secondary structure of exenatide in ELPM6 microspheres can be maintained after the W/O/W-SE and lyophilization processes using a combination of various stabilizers [28,31]. On the other hand, for exenatide extracted from ELPM1 without protective additives in the formulation, a significant difference in the two minima at 209 and 224 nm was observed in the spectrum, implying a change in the secondary structure.…”
Section: Secondary Structure Stability Of Exenatide In Plga Microspherementioning
confidence: 96%
See 1 more Smart Citation
“…The CD spectra of exenatide had two specific minima at 209 and 224 nm wavelength, which indicated the presence of α-helix (Figure 8a) [25]. There was no difference between the extracted exenatide from ELPM6 and the unprocessed one, which means that the secondary structure of exenatide in ELPM6 microspheres can be maintained after the W/O/W-SE and lyophilization processes using a combination of various stabilizers [28,31]. On the other hand, for exenatide extracted from ELPM1 without protective additives in the formulation, a significant difference in the two minima at 209 and 224 nm was observed in the spectrum, implying a change in the secondary structure.…”
Section: Secondary Structure Stability Of Exenatide In Plga Microspherementioning
confidence: 96%
“…For example, adverse effects like vomiting may increase with higher rates of exenatide burst release [11]. Many groups are currently attempting to suppress exenatide burst release and the incomplete release of commercial products [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31]. Although many investigations into exenatide formulations and dosages have been performed, there is still a lack of useful information about exenatide stability.…”
Section: Introductionmentioning
confidence: 99%
“…The morphology of CLX coarse powder was evaluated using scanning electron microscope (SEM, S-3000N, Hitachi, Japan). 33 Prior to examination, samples were mounted onto a metal stub using a carbon double sided adhesive tape, and further sputtered with a thin layer of gold palladium. The instrument was operated at a voltage of 10 kV.…”
Section: Characterization Of Nanosuspensionsmentioning
confidence: 99%
“…The cytotoxicity of each constituent isolated from polysorbate 80 was evaluated using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide) colorimetric test by calculating the percentage of viable cells. 16,17 In brief, LO2 cells were seeded in 96-well plates at a density of 5000 cells per well in RPMI 1640 medium containing 5% FBS and allowed to grow overnight. Aer incubation with each constitute at serial concentrations (10, 25, 50, 100, 200, 300, 400 and 500 mg mL À1 ) at 37 C for 24 h, 200 mL of MTT (5 mg mL À1 ) was added to each well.…”
Section: Mtt Assaymentioning
confidence: 99%